How much does a Workplace Drug Testing Service cost to buy?

A typical Workplace Drug Testing Service sells for 3x to 5x seller's discretionary earnings. With estimated SDE of $173K, expect to pay roughly $518K to $863K before adjustments for assets, debt, growth, and local market quality.

How much does it cost to start a Workplace Drug Testing Service?

Startup costs range from $30K to $175K depending on location, equipment, and scale.

Service

Workplace Drug Testing Service

Compliance testing for employers who cannot afford bad hires or failed audits

Bottom line

Worth studying, but do not buy without strong local proof.

Workplace drug testing companies provide pre-employment, random, post-accident, and DOT-compliant testing for employers. Demand is driven less by consumer taste and more by insurance, safety, regulation, and HR policy — which makes it a quietly durable boring business.

See listings →Compare ↔

Share LinkedInReddit HN

Acquisition score

Margin · multiple · SBA data

41Fair

Avg revenue

$750K/yr

$200K–$2M range

Profit margin

23%

~$173K SDE

Multiple

3–5×

of SDE

Est. buy price

$518K–$863K

startup: $30K–$175K

How It Works

The operator contracts with employers, staffing firms, schools, and transportation fleets to run scheduled and on-demand tests. Revenue comes from urine, saliva, hair, and instant tests, plus consortium management, mobile collections, and occupational health add-ons. The best firms win on turnaround speed, chain-of-custody reliability, and account retention.

BizBite verdict

Watch / verify

Workplace Drug Testing Service maps to the Workplace Drug Testing Service model. The category can work for acquisition buyers, but the right answer depends on source freshness, verified economics, and the specific red flags below.

41Fair

medium data confidence · 72/100medium financing fit

Why it may work

+SBA dataset shows 3 recent comparable loans
+5 clear operating upside levers identified

Be careful

!Source link status has not been verified yet
!No last-checked date yet

Category operating model

Workplace Drug Testing Service

medium labor

low capex

medium owner

Revenue drivers

• Specimen collections by site, employer count, modality, collector utilization, and same-day scheduling capability
• Third-party administrator revenue: random pools, compliance reporting, policy support, MRO/lab coordination, and portal fees
• DOT-regulated employer accounts, FMCSA clearinghouse/compliance workflows, and random-testing cadence
• Onsite event volume for construction, logistics, manufacturing, healthcare, schools, and government contractors
• Lab pass-through margin, collection fees, after-hours/mobile premiums, and ancillary background/physical services

Key risks

• Lab and MRO partners may capture most margin unless the operator owns employer workflow and admin value
• Chain-of-custody defects can force recollections and damage regulated-client trust
• Regulation and marijuana-policy changes can reduce some testing categories while increasing complexity
• Revenue concentration can hide inside a few construction, staffing, or trucking accounts
• Owner relationship sales and compliance knowledge may not transfer without documented processes

What you need to believe

The company owns employer compliance workflow, not just low-margin specimen collection labor.
Recurring DOT/random-pool and employer accounts survive the sale and renew under documented processes.
Collection quality, chain-of-custody, and turnaround are good enough for regulated customers.
Gross margin remains after lab/MRO pass-through, mobile labor, recollections, and account-management costs.

Unit economics

How one unit makes money

Modeled per one local collection/TPA operator serving employer accounts, onsite events, and DOT/random testing programs. Every line shows its arithmetic — rebuild any number yourself.

Revenue build-up

Line	Low	Base	High
Collection fees for pre-employment, random, post-accident, and reasonable-suspicion tests6,000 collections/year × $50 average collection/client fee in base case	$70K	$300K	$800K
Lab/MRO/TPA admin margin and random-pool programs250 employers × ~$85/month admin/pool/reporting average plus per-test admin spread	$80K	$250K	$650K
Onsite/mobile testing events120 onsite events/year × $1,000 blended ticket from mobilization plus volume fees	$30K	$120K	$350K
Ancillary background checks, physicals coordination, training, after-hours premiums100 employer clients × ~$800/year add-on average, with pass-through costs normalized	$20K	$80K	$200K

Where it goes — cost structure

Collectors, mobile staff, scheduling, payroll burden22–38%
Collectors need procedure discipline; observed/mobile/after-hours work lifts labor cost.
Lab fees, MRO fees, kits, shipping, portal fees24–42%
Pass-through cost can make headline revenue misleading if gross margin is not split by product.
Occupancy, mobile mileage, insurance, supplies5–11%
Collection sites are light capex, but mobile events carry travel and utilization risk.
Sales, account management, compliance QA, admin10–18%
TPA value lives in renewals, reporting, and compliance support, not cups alone.
Recollections, disputes, bad debt, software, misc3–8%
Invalid specimens and slow-pay employers quietly leak margin.

SDE margin · low

15%

SDE margin · base

23%

SDE margin · high

30%

What actually swings the deal

Collection volume
±1,000 collections at $50 fee changes revenue by ±$50K before labor and lab/MRO pass-through.
Employer admin ARPU
±$25/month across 250 employers changes recurring revenue by ±$75K/year.
Lab/MRO cost spread
$5 cost movement across 6,000 tests changes SDE by about ±$30K if pricing is not adjusted.
Invalid/recollection rate
A 2% recollection rate on 6,000 tests at $35-$60 internal cost costs roughly $4K-$7K plus client trust.

Benchmarks to memorize

Profile midpoint revenue$750K

Profile SDE margin23%

Profile multiple range3x-5x SDE

Regulated testing procedures49 CFR Part 40 / SAMHSA federal collection guidance

The ceiling

Collection-only operators hit a labor and pricing ceiling quickly. The scalable base case needs 6,000 annual collections plus roughly 250 employer relationships paying for admin, random pools, reporting, or onsite workflow; otherwise the business is a thin-margin lab pass-through desk.

Market analysis

Who owns these & where demand comes from

A workflow and compliance service layered on top of labs, MROs, collectors, and employer HR/safety teams. Local operators win convenience and account management; national players win scale and lab infrastructure.

Tailwinds

↗ Compliance complexity supports TPA/admin revenue even when testing modality changes
↗ Mobile and onsite testing saves employers downtime and improves scheduling
↗ Portal/reporting workflows can turn local accounts into sticky recurring contracts

Headwinds

↘ Lab/MRO pricing power and national clinic networks squeeze commodity collection margin
↘ Changing cannabis rules and hiring-market pressure can reduce some pre-employment volumes
↘ Privacy, chain-of-custody, and turnaround failures quickly damage trust

Demand drivers

DOT-regulated transportation employers require formal drug and alcohol testing procedures
Construction, logistics, manufacturing, healthcare, schools, staffing, and government contractors use testing to manage safety and compliance risk
Random, post-accident, reasonable-suspicion, return-to-duty, and follow-up programs create recurring work beyond pre-employment screens
Employers outsource collection, reporting, and policy administration because mistakes are operationally painful

Regulation

High for regulated clients. DOT Part 40 governs transportation workplace testing procedures; SAMHSA federal guidance defines trained collector and specimen-collection expectations. State employment/privacy rules and employer policy design also matter.

Who you bid against

Buyers include occupational-health clinics, background-check/compliance platforms, labs, local collection-site operators, and searchers looking for recurring B2B compliance accounts. Collection-only shops get lower bids than TPA/admin books.

Competitive advantage

What protects the good ones

strongEmployer compliance workflow
Random pools, policy records, reporting cadence, and DOT workflows create switching friction beyond a local collection site.
moderateCollector QA and chain-of-custody reliability
Regulated clients will leave if specimens are mishandled, but procedure quality can be replicated with training.
moderateOnsite/mobile availability
Fast events for job sites and fleets win accounts, but require scheduling discipline more than heavy capex.

Who wins — and who loses

The winner is not the cheapest cup-and-clipboard shop. It owns employer policy calendars, random pools, DOT reporting workflows, collector QA, and fast onsite scheduling. The loser passes lab invoices through, handles walk-ins, and discovers compliance defects only when a client is already angry.

How this niche degrades

↘ National labs and occupational-health chains can compress collection/lab pricing
↘ Marijuana-law and employer-policy changes may reduce some pre-employment testing volumes
↘ Chain-of-custody or privacy failures can trigger client loss and liability
↘ A few staffing/fleet/construction customers can dominate volume and churn abruptly

Consolidation status

Moderately fragmented at the local level, but national labs, occupational-health clinics, background-check platforms, and TPA vendors control parts of the stack. A local buyer wins by owning employer relationships and mobile service rather than trying to out-scale Quest/Labcorp on lab economics.

SBA 7(a) data

Real acquisitions in this category

Change-of-ownership loans · NAICS 621999 · All Other Miscellaneous Ambulatory Health Care Services

Deals tracked

3 in last 24 mo

Median loan

$330K

$250K–$646K p25–p75

Implied deal size

$388K

median · ~85% LTV

Charge-off rate

—

not enough resolved loans

Deal size distribution

<$150K

$150K–500K

$500K–1M

$1M–2M

>$2M

Financing profile

Median rate

8.50%

33% fixed · last 24 mo

Median term

120 mo

standard 10-yr

Collateralized

of loans secured

Median jobs

supported per deal

Top lenders in this space

Live Oak Banking Company2

Old National Bank2

Renasant Bank1

The Bancorp Bank National Association1

Wells Fargo Bank National Association1

Where deals happen

MN3

WI2

CA2

AL1

MI1

TX1

WA1

AZ1

NC1

Recent comparable deals

Closed	State	Loan	Implied deal	Jobs	Franchise
Dec 2024	WI	$150K	$177K	18	—
Dec 2024	WI	$712K	$838K	18	—
Jun 2024	MI	$852K	$1.0M	55	—
Apr 2024	MN	$250K	$294K	82	—
Apr 2024	MN	$1.4M	$1.6M	82	—
Jun 2023	AZ	$435K	$512K	12	—
Feb 2023	AL	$295K	$347K	10	—
Sep 2022	WA	$646K	$760K	27	—
Sep 2021	MN	$59K	$69K	2	Stroller Strides
Jun 2021	CA	$250K	$294K	35	—

Volume rank #338/544Deal-size rank #502/544p90 loan: $712KData as of Mar 2026

Source: SBA 7(a) FOIA dataset, filtered to acquisitions (loans where business age is "Change of Ownership"). Implied deal size assumes an 85% loan-to-purchase ratio, a common SBA change-of-ownership structure. Charge-off rate shown only when 10+ loans have resolved (paid in full or charged off). Interest rates reflect last 24 months only. Actual deal values vary with equity injections, seller financing, and working capital terms.

Valuation framework

How these actually get priced

Value on normalized SDE, separating low-margin lab pass-through revenue from recurring employer admin, random-pool, onsite, and collection economics. Premiums go to contracted recurring employer accounts, DOT/random compliance workflow, clean QA, low concentration, and transferable lab/MRO/software relationships.

Basis: SDE

What moves the multiple

▲ PremiumRecurring employer/admin revenue
Monthly TPA, random-pool, portal, and compliance support fees are stickier than one-off pre-employment tests.
▲ PremiumDOT/compliance workflow quality
Regulated accounts with clean audit trails and collector QA are harder to replace.
▼ DiscountLab pass-through mix
High gross revenue with low retained spread should not receive the same multiple as admin margin.
▼ DiscountClient concentration and policy risk
Staffing or construction account churn can sharply reduce volume.

Worked example

The profile midpoint is $750K revenue at a 23% margin, or about $172.5K SDE. At the stated 3x-5x SDE range, indicated value is roughly $518K-$863K. The high end requires recurring employer/admin revenue, DOT/random accounts, clean collector QA, and low concentration; a walk-in/pass-through collection site belongs well below that.

Common buyer mistakes

✕ Applying a premium multiple to lab pass-through revenue instead of retained gross profit
✕ Ignoring chain-of-custody defects, recollections, and turnaround complaints
✕ Assuming testing demand is static despite employer marijuana-policy changes
✕ Buying client volume without checking contract status, renewal dates, and account-owner relationships

Deal Calculator

Priced off $173K SDE — can this deal service its own debt?

1.87×

DSCR · Lender-comfortable

Purchase multiple — 4.0× SDE ($690K)

Category range: 3×–5× SDE

Down payment — 10% ($69K)

SBA minimum equity injection is 10% for change-of-ownership

Interest rate — 8.50%

SBA median for this category: 8.5%

Loan term — 10 years

SBA median for this category: 120 months

Purchase price

$690K

4.0× of $173K SDE

Cash to close

$90K

$69K down + ~3% closing

Debt service

$8K/mo

$92K/yr on $621K loan

Cash-on-cash

89%

cash back in ~14 mo

Debt service coverage · what the lender sees

1.87×+$7K/mo after debt

Most SBA lenders want ≥1.25× coverage; 1.5×+ is a strong file.

SDE = revenue × margin estimate for this niche; it includes owner compensation, so budget your salary out of cash flow. Excludes working-capital injection, capex reserves, and taxes. Actual SBA terms vary by lender and borrower.

Due diligence checklist

Before you sign anything

01
Split revenue and gross profit by collection fee, lab pass-through, MRO, TPA/admin, random pool, onsite/mobile, DOT, non-DOT, and ancillary services.
The valuation depends on retained margin and recurring workflow, not headline test volume.
Red flagSeller cannot separate lab costs or admin fees from total testing revenue.
02
Export employer accounts with contract status, monthly/admin fees, testing volume, renewal date, DOT status, random-pool participation, and concentration.
Employer account quality sets retention and multiple.
Red flagA few staffing or construction clients drive most specimens without contracts.
03
Audit collector training, chain-of-custody procedures, invalid/recollection rate, QA logs, disputed results, and privacy incidents.
Compliance quality protects regulated-client trust.
Red flagNo formal collector QA or repeated specimen defects.
04
Review lab, MRO, portal/software, background-check, and occupational-health partner agreements for pricing, transfer, data ownership, and termination.
The stack must transfer for revenue to continue.
Red flagCritical pricing or portals are personal to the seller or cancellable on short notice.
05
Measure turnaround time, scheduling responsiveness, onsite-event profitability, mobile mileage, and after-hours labor.
Service quality and mobile utilization drive account retention.
Red flagOnsite jobs look large but lose money after travel, staff idle time, and recollections.
06
Check policy/legal exposure: DOT procedures, state employment/privacy rules, adverse-action support, client indemnities, insurance, and open disputes.
Regulated testing errors can become legal or account-loss events.
Red flagThe seller gives policy/legal advice without documentation, insurance, or qualified review.

Pros

+Compliance-driven recurring demand from employer accounts
+High trust and operational discipline create retention
+Mobile collections and after-hours testing support premium pricing
+Cross-sells naturally into background screening and occupational health

Cons

-Documentation errors can create liability
-Account concentration can hurt if one big employer leaves
-Some growth depends on local labor-market conditions
-Clinical compliance and collector training matter

Best For

Operators who like B2B compliance services, account management, and process discipline

Operating Costs

Key costs include collectors, lab fees, rent, software, insurance, and sales. Grand View Research estimated the U.S. drug screening market at about $2.54B in 2023, while the U.S. drug-of-abuse testing services market was roughly $992.6M in 2024, showing how large the employer and safety-testing niche already is.

Deep Dive

Deep Dive: Workplace Drug Testing Services • 2026-07-06

BizBite Deep Dive — Workplace Drug Testing Services

1) Executive Summary (5 bullets)

Workplace drug testing is a boring B2B compliance business: employers pay because safety rules, insurance requirements, DOT programs, hiring workflows, and post-accident procedures force repeat demand.
The acquisition target is not a lab science startup. It is usually a local clinic, collection site, mobile collector, or third-party administrator with employer accounts, clean chain-of-custody process, and lab/MRO relationships.
Best buyer thesis: buy a subscale operator at 3.0x-4.5x SDE, tighten scheduling and documentation, add mobile collections, and cross-sell background checks, physicals, and DOT consortium management.
Main risks are documentation errors, account concentration, state-by-state drug policy changes, weak collector training, slow lab turnaround, and owner-dependent employer relationships.
Underwriting target: 20-30% EBITDA/SDE margin after paying replacement labor, less than 20% revenue from the top customer, documented recurring employer accounts, and at least 1.25x post-debt service coverage under conservative volume assumptions.

2) Market Research (TAM/SAM/SOM-style reasoning)

What the market is

Services sold: pre-employment screens, random testing, post-accident testing, reasonable-suspicion testing, return-to-duty programs, DOT consortium administration, alcohol breath tests, mobile/on-site collections, and policy support.
Core buyers: trucking fleets, logistics operators, construction companies, staffing agencies, manufacturers, schools, municipalities, healthcare employers, energy/utility contractors, and any employer with safety-sensitive roles.
Demand trigger is operational risk, not fashion. A failed audit, workplace accident, insurance requirement, or hiring backlog creates urgency.

TAM

Grand View Research estimated the U.S. employer and workplace drug testing market at about $2.57B in 2024, with a path toward roughly $4.01B by 2033 at about 5.2% CAGR.
Broader U.S. drug-of-abuse testing services estimates around $1B+ reinforce that this is a real services market, not a tiny niche.
TAM includes national labs and big occupational-health platforms, so a local acquisition buyer should not pretend all TAM is reachable.

SAM

For one metro operator, the practical SAM is employers within 30-60 minutes that need recurring testing or fast local collection.
Example metro math: 2,000 target employers x 35 covered employees average x 1.2 tests per covered employee per year x $55 blended gross collection/testing revenue = about $4.6M local annual testing spend.
Narrower compliance-heavy SAM: 400 fleet/construction/staffing employers x 60 covered workers x 1.5 tests per worker x $65 blended = about $2.34M.

SOM

A defensible first-five-year SOM for a small buyer is 3-8% of local SAM if the company has direct employer relationships and reliable turnaround.
On the $2.34M compliance-heavy SAM above, 5% share is $117K revenue; 15% share is $351K. That is why acquisitions beat startups here: existing account density matters.
A strong local platform can reach $750K-$2M revenue by combining clinic volume, mobile collections, DOT administration, and occupational-health add-ons.

3) Moat Analysis

Compliance process: chain-of-custody accuracy, collector training, documented procedures, and audit readiness create real switching friction.
Employer account trust: HR and safety managers hate vendor changes once testing is reliable. Speed and zero-drama reporting matter more than brand polish.
Lab and MRO relationships: established pricing, portals, reporting workflows, and turnaround expectations reduce operational friction.
Route density and mobile coverage: mobile collections turn urgent jobs into premium-priced revenue and make the operator harder to replace for fleets and job sites.
Data hygiene: a clean roster of covered employees, random pool schedules, test history, policy documents, and contact workflows is a small but durable moat.
Weak moat if: the business is just a walk-in collection site with no employer contracts, no recurring cadence, no mobile capability, and no proprietary account relationships.

4) Unit Economics (3 concrete scenarios with numbers)

Scenario A — Small collection clinic, mostly pre-employment

Monthly volume: 450 tests at $58 average revenue = $26,100.
Direct lab/MRO/test-kit cost: $20 per test = $9,000.
Gross profit: $17,100, or 66% gross margin.
Fixed monthly overhead: collector/admin payroll $7,500, rent $2,200, software/portal $600, insurance $400, marketing/admin $900.
Monthly SDE before owner replacement: $5,500; annualized SDE: $66,000.
Acquisition view: at 3.0x SDE, price is about $198K. This only works if the buyer can either operate directly or prove replacement labor is already included.

Scenario B — Employer account base plus DOT consortium administration

75 employer accounts averaging 18 tests/year at $65 = $87,750 annual test revenue.
600 covered drivers/workers paying $120/year admin fee = $72,000 annual recurring admin revenue.
Mobile/on-site fees: 220 visits/year at $95 net service fee = $20,900.
Total revenue: $180,650.
Direct costs: tests/lab/MRO at 34% of test revenue = $29,835; mobile labor/fuel $9,000; software/compliance $8,400; admin payroll $48,000; rent/insurance/misc $18,000.
Annual SDE: about $67,400, or 37% before owner sales time; normalize to $45K-$55K if the owner is doing heavy unpaid account management.
Acquisition view: pay 3.0x-3.8x normalized SDE only if accounts transfer cleanly and random-pool data is organized.

Scenario C — Mature local platform with mobile industrial accounts

Revenue mix: 9,000 annual tests at $62 = $558,000; DOT/admin fees $140,000; mobile and after-hours fees $125,000; occupational-health add-ons $175,000.
Total revenue: $998,000.
Direct testing/lab/kit/MRO cost at 32% of test revenue = $178,560.
Field collectors and admin payroll: $310,000.
Rent, vehicles, fuel, insurance, software, sales, training, and G&A: $255,000.
EBITDA/SDE: about $254,000, or 25% margin.
Acquisition view: 4.0x SDE implies about $1.02M enterprise value. With 10% seller note and 10% holdback, a buyer reduces transfer risk and preserves cash for working capital.

5) Due Diligence Checklist

Pull 36 months of P&L, tax returns, bank statements, merchant deposits, customer-level revenue, and test volume by type.
Separate revenue into pre-employment, random, post-accident, DOT consortium/admin, mobile collections, alcohol testing, and occupational-health add-ons.
Rebuild gross margin by test type: price charged, lab/MRO cost, supplies, collector time, travel time, failed/no-show appointments, and redraw/retest rates.
Verify top 20 customers: contract terms, renewal dates, pricing, volume, decision-maker, transferability, and last 12-month test count.
Review lab agreements, MRO agreements, collector certifications/training, software subscriptions, privacy/security practices, and complaint history.
Audit chain-of-custody samples from intake to result delivery. One sloppy file is a process issue; many sloppy files are a deal problem.
Confirm DOT program handling: random pool generation, selection notices, completion tracking, annual MIS reporting support, return-to-duty process, and record retention.
Validate mobile economics by riding along: travel time, cancellations, site access, wait time, after-hours premiums, and collector utilization.
Check insurance coverage, leases, vehicle titles/leases, equipment list, open claims, state licensing rules, and any medical director/clinical oversight requirements.
Call 10 customers before close, with seller permission, to verify satisfaction, why they use the company, and whether they would stay after transition.

6) What to Watch For

Marijuana policy changes can reduce pre-employment volume in some roles, but safety-sensitive, DOT, post-accident, and reasonable-suspicion testing remain durable.
Top-customer concentration above 25-30% of revenue should lower the multiple or require earnout/retention protection.
Lab turnaround problems can look like vendor issues but cause customer churn at the local operator level.
Owner-dependent sales is common. If the owner personally knows every HR manager and nothing is in the CRM, assume transition risk.
Low advertised test prices may exclude MRO, confirmation testing, collection fees, or admin work. Underwrite actual gross profit, not menu price.
Privacy, documentation, and chain-of-custody failures can create legal exposure and destroy trust fast.
No-shows and same-day cancellations quietly kill utilization, especially for mobile collectors.

7) How to Finance the Acquisition

SBA 7(a): viable when cash flow is documented, buyer has enough operating competence, and the business is not dependent on unverifiable cash or one customer.
Seller financing: ask for 10-25% of purchase price on a 3-5 year note. This aligns the seller around account transition and documentation quality.
Retention holdback: hold back 5-15% of price for 90-180 days tied to retained revenue from named employer accounts.
Earnout: useful when the seller claims growth from large employer accounts that are not yet proven. Pay only as revenue materializes.
Working capital: reserve 1-2 months of payroll, lab payables, supplies, software, insurance, and vehicle costs. A $750K-revenue operator can need $60K-$120K liquidity.
Do not overfinance equipment: most value is in relationships and process, not chairs, cups, and office furniture. Vehicles and lab equipment should be valued conservatively.

8) Valuation & Deal Structure Cheatsheet

Tiny owner-operated collection site: 2.0x-3.0x normalized SDE if customer records are weak or owner replacement is not included.
Documented employer-account business: 3.0x-4.0x SDE with transferable accounts, clean gross-margin data, and low concentration.
Scaled local platform: 4.0x-5.0x SDE/EBITDA if revenue is diversified, mobile routes are dense, admin fees recur, and the management team can run without the seller.
Discounts: subtract for weak chain-of-custody files, no contracts, top-customer concentration, expiring lease, no CRM, thin collector bench, or pending compliance disputes.
Premiums: pay more for written employer contracts, recurring DOT/admin fees, dense mobile routes, low churn, clean systems, and occupational-health cross-sell.
Preferred structure: 75-85% cash at close, 10-20% seller note, 5-10% retention holdback, plus a working-capital target based on normal payroll and lab payables.
Debt test: post-close cash flow should cover debt service by at least 1.25x after paying a real operator salary and reserving for working capital.

9) 10 Questions to Ask the Owner

What percentage of revenue is pre-employment, random, DOT, post-accident, mobile, admin fees, and occupational-health add-ons?
Who are the top 20 customers, how long have they been customers, and what revenue did each generate in the last 12 months?
Are customer relationships under written contract, master service agreement, portal setup, or handshake?
What is the average price and gross profit per test type after lab, MRO, supplies, labor, and travel time?
How are chain-of-custody records stored, audited, and corrected when errors occur?
Which labs, MROs, and software platforms are used, and can those agreements transfer to a buyer?
How many active collectors are trained, what can each perform, and who covers after-hours/post-accident calls?
What customer churn occurred in the last 24 months and why?
What compliance issue, complaint, audit finding, or legal dispute has happened in the last five years?
If you disappeared for 30 days, which customers, processes, or sales activities would break first?

10) 7-Day Action Plan

Build a local target list of drug testing clinics, occupational-health sites, mobile collectors, and DOT consortium administrators within 60 miles.
Pull every public review and classify complaints by speed, professionalism, documentation, hours, and result turnaround.
Call as a mystery-shopper employer and request pricing for 20 pre-employment screens, random DOT pool setup, and one on-site collection day.
Create a one-page underwriting template with test volume, gross profit per test, admin-fee revenue, mobile utilization, top-customer concentration, and replacement labor.
Contact 20 owners with a direct acquisition note focused on continuity, confidentiality, and protecting employer relationships.
For any seller reply, request customer-level revenue, test volume by type, lab/MRO costs, software stack, and top-10 account concentration before discussing price.
Issue an LOI only if the deal clears three gates: less than 25% top-customer concentration, clean chain-of-custody samples, and at least 1.25x debt-service coverage after owner replacement.

BizBite Deep Dive | July 6, 2026 | Workplace Drug Testing Services